CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study

Stroke
|June 30, 2007
PubMed

Insights

C-reactive protein (CRP) gene variations are not associated with cerebral small-vessel disease (SVD). These findings suggest CRP is not a causal factor in SVD pathogenesis.

Area of Science:

  • Genetics
  • Neurology
  • Cardiovascular Science

Background:

  • Investigated the role of C-reactive protein (CRP) in atherosclerosis and atherothrombotic disease.
  • Examined the association between CRP gene variations and cerebral small-vessel disease (SVD) in two independent cohorts: the Rotterdam Scan Study and the MEMO Study.

Discussion:

  • Analyzed common CRP gene haplotypes using genotype-tagging single-nucleotide polymorphisms.
  • Explored the relationship between CRP haplotypes and markers of cerebral SVD, including white matter lesions and lacunar infarcts, via regression analyses.

Key Insights:

  • No significant association was found between CRP gene haplotypes and measures of cerebral SVD in either study cohort.
  • CRP gene variations did not modify the association between serum CRP levels and cerebral SVD markers.

Outlook:

  • The study suggests C-reactive protein (CRP) is unlikely to be causally implicated in the pathogenesis of cerebral small-vessel disease.
  • Further research may explore other inflammatory markers or genetic factors in SVD development.
Abstract